Index Biosystems
PrivateLast Round
Series A
Jan 1, 2025
Total Funding Raised
$6.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Index Biosystems operates in Frontier & Industrial Tech and is based in Burlington. Its latest recorded funding round was a Series A round in January 2025.
Index Biosystems is a biotechnology company that provides an AI-powered platform and molecular-based traceability solutions for food safety and manufacturing operations.
Sector
Frontier & Industrial Tech
Verticals
Biotechnology, Supply Chain Tracking, Compliance & Risk, Supply Chain, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Index Biosystems Comparables
Compare Index Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Natural Trace | 83% | |
| TruTag Technologies | 76% | |
| Merck & Co., Inc. | 73% |
For institutional investors. Book with your work email.
Index Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 1, 2025 | ||||
| Seed | Jun 18, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Index Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vanedge Capital | Seed |
| Creative Destruction Lab | Seed |
| Conscience VC | Series A |
| Undeterred Capital | Series A |
| Ferment | Series A |
| CoFound Partners | Series A |
| Trailhead Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 200% MoM.
- May 1, 2025
Monthly visitors grew 3006% MoM, from 17 to 528.
For institutional investors. Book with your work email.
Index Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Index Biosystems's valuation, stock price, and market status.
Is Index Biosystems a public or private company?
Index Biosystems is a private company.
What is the current stock price of Index Biosystems?
Index Biosystems is a private company, so its shares have no public market price. Caplight tracks Index Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Index Biosystems worth (valuation)?
Valuation information for Index Biosystems is not publicly available.
Can I buy Index Biosystems stock?
Index Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Index Biosystems's last funding round?
Index Biosystems's most recent funding round was Series A on January 1, 2025.
Who are the main investors in Index Biosystems?
Key investors in Index Biosystems include Vanedge Capital, KdT Ventures.
Will Index Biosystems IPO soon?
No public IPO plans have been announced for Index Biosystems.
How can I track Index Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Index Biosystems's shares on secondary markets.